Reactivation of Hepatitis in a Bladder Cancer Patient Receiving Chemotherapy
β Scribed by Hiroshi Higashiyama; Toru Harabayashi; Nobuo Shinohara; Makoto Chuma; Shuhei Hige; Katsuya Nonomura
- Book ID
- 106554764
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 90 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Breast cancer is a rapidly increasing problem in many developing countries, and cytotoxic chemotherapy is now an integral part of its management. In several developing countries, the carriage of hepatitis B virus (HBV) in cancer patients may be as high as 12%, and such patients are at r
## Abstract A 53βyearβold man who had a history of fluminant hepatitis caused by precore mutant hepatitis B virus (HBV) was admitted to our hospital for the treatment of relapsed nonβHodgkin's lymphoma in July 2000. At admission, serum levels of aspartate aminotransferase and alanine aminotransfera
## Abstract The combination of CEA, hepatic function marker enzymes, and four acute phase reactant proteins (haptoglobin, Ξ±~1~ antitrypsin, Ξ±~1~ acid glycoprotein, and prealbumin) has been used to monitor patients with colorectal cancer receiving chemotherapy. In 18 patients with advanced lesions